Tobramycin antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Tobramycin antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-18-1 | 1. BSA-Tobramycin 2. Anti-Tobramycin mouse monoclonal antibody | $2709.00 |
GMP-SMT-18-2 | 1. OVA-Tobramycin 2. Anti-Tobramycin mouse monoclonal antibody | $2709.00 |
GMP-SMT-18-3 | 1. BSA-Tobramycin 2. Anti-Tobramycin human monoclonal antibody | $2709.00 |
GMP-SMT-18-4 | 1. OVA-Tobramycin 2. Anti-Tobramycin human monoclonal antibody | $2709.00 |
GMP-SMT-18-Ag-1 | BSA-Tobramycin | $756.00 |
GMP-SMT-18-Ag-2 | OVA-Tobramycin | $756.00 |
GMP-SMT-18-Ab-1 | Anti-Tobramycin mouse monoclonal antibody | $1953.00 |
GMP-SMT-18-Ab-2 | Anti-Tobramycin human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Tobramycin
Cat No. | GMP-SMT-18-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Tobramycin with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Tobramycin had been validated with our anti-Hapten antibody Anti-Tobramycin mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Tobramycin
Cat No. | GMP-SMT-18-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Tobramycin with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Tobramycin had been validated with our anti-Hapten antibody Anti-Tobramycin mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Tobramycin mouse monoclonal antibody
Cat No. | GMP-SMT-18-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 5.00 |
Products description | The anti-Hapten antibody against hapten Tobramycin had been validated with our hapten hapten-carrier conjugates BSA-Tobramycin via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Tobramycin human monoclonal antibody
Cat No. | GMP-SMT-18-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 5.00 |
Products description | The anti-Hapten antibody against hapten Tobramycin had been validated with our hapten hapten-carrier conjugates BSA-Tobramycin via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
1. Tobramycin in Veterinary Settings: A Comprehensive Analysis
Tobramycin, a vital member of the aminoglycoside antibiotic family, plays a crucial role in veterinary medicine. In this comprehensive analysis, we explore its multifaceted presence in veterinary drug residues and as an additive in animal feed. We delve into its significance, measurement, and the impact on animal and human health.
Role in Veterinary Drug Residues:
Tobramycin, when administered to animals, leaves residues in various tissues, including meat and milk products (1). These residues can raise concerns about food safety and antibiotic resistance.
Food Safety Concerns (1, 2): The presence of Tobramycin residues in animal-derived products has raised considerable concerns in the context of food safety. Consuming products with elevated Tobramycin residues can lead to adverse health effects in humans. This makes it crucial to monitor and regulate Tobramycin levels in food products derived from treated animals.
Antibiotic Resistance Implications (2, 3): The use of antibiotics like Tobramycin in veterinary medicine can contribute to the development of antibiotic-resistant strains of bacteria. When animals are exposed to antibiotics, they may develop antibiotic-resistant bacteria in their systems. This raises the risk of antibiotic-resistant zoonotic infections, which can be transmitted from animals to humans. Monitoring and controlling Tobramycin residues are essential to prevent the emergence of antibiotic-resistant bacteria and safeguard public health.
Role in Additives:
Tobramycin also finds applications as an additive in animal feed, particularly for livestock that are susceptible to bacterial infections (1). Accurate measurement of Tobramycin content in these additives is vital for several reasons:
Preventing Overexposure (1, 2): Overexposure to Tobramycin can have detrimental effects, including the development of antibiotic-resistant bacteria. When used as an additive, precise measurement of Tobramycin content ensures that animals receive the therapeutic benefits without being exposed to excessive antibiotic levels. This not only safeguards animal health but also minimizes the risk of antibiotic resistance.
Compliance with Regulatory Standards (2, 3): In the production of animal feed, regulatory standards and guidelines dictate permissible levels of Tobramycin as an additive. Accurate measurement and adherence to these standards are crucial to ensure compliance with regulations. Non-compliance can result in legal consequences and may compromise the quality of the final products.
The Significance of Tobramycin Measurement:
Accurate measurement of Tobramycin in veterinary settings holds immense importance due to its far-reaching implications.
Ensuring Food Safety:
Precise measurement of Tobramycin levels in animal-derived products is paramount for ensuring consumer safety. It helps in adhering to established maximum residue limits (MRLs), which are the allowable concentrations of drug residues in food products. Monitoring and controlling Tobramycin residues in meat and milk products is essential to prevent health risks related to Tobramycin exposure through consumption (3, 4).
Controlling Antibiotic Resistance:
One of the most pressing global health challenges is the rise of antibiotic-resistant bacteria. In veterinary medicine, overuse and improper administration of antibiotics, including Tobramycin, are significant contributing factors. Monitoring Tobramycin levels is pivotal in the global effort to combat antibiotic resistance (4, 5). By ensuring that antibiotic residues in animals are within safe limits, we can reduce the selective pressure that drives the evolution of antibiotic-resistant bacteria. This, in turn, benefits both animal and human health.
Compliance and Quality Assurance:
Regulatory compliance is upheld through accurate Tobramycin measurement, ensuring that veterinary products, including animal feed, meet industry standards. In animal feed production, precise measurement guarantees the additive's therapeutic efficacy without compromising animal health (5, 6). Compliance with regulatory standards is essential not only to meet legal requirements but also to maintain product quality and safety.
In conclusion, the thorough analysis and precise measurement of Tobramycin are of utmost importance in veterinary settings. It helps ensure food safety, control antibiotic resistance, and maintain regulatory compliance. Our company, equipped with advanced technologies utilizing anti-Tobramycin antibodies and competitive antigens, is committed to assisting veterinary professionals in achieving these critical objectives. Our scientific expertise and products contribute significantly to animal and human welfare alike, making a positive impact on the health and safety of all stakeholders in the veterinary industry.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.